NIH R01 · 2025
Blood pressure (BP) measurement by a provider in the clinic, “attended clinic BP”, is the primary method for diagnosing and managing hypertension (HTN). BP may differ inside versus outside of clinic. Ambulatory BP monitoring (ABPM) measures out-of-clinic BP. Compared with attended clinic BP, BP during the awake period on ABPM (“awake BP”) is a better predictor of cardiovascular (CVD) risk. Guidelines recommend ABPM to identify white coat HTN (having high clinic BP but not having high awake BP) and masked HTN (not having high clinic BP but having high awake BP). In most ABPM studies, white coat HTN is not associated with an increased risk of target organ damage and CVD, whereas masked HTN is…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.